サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467879

不妊検査市場レポート：製品、購入形態、用途、エンドユーザー、地域別、2024～2032年

Fertility Test Market Report by Product, Mode of Purchase, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
不妊検査市場レポート：製品、購入形態、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の不妊検査市場規模は、2023年に5億5,230万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに9億2,760万米ドルに達し、2024～2032年の間に5.8％の成長率（CAGR）を示すと予測しています。

不妊検査は、カップルの妊娠を妨げる問題を診断するために行われます。血液検査、骨盤内検査、精液分析、基礎体温（BBT）チャート作成、性交後検査、経膣（骨盤）超音波検査、子宮卵管造影またはHSG、子宮鏡検査、腹腔鏡検査で構成されます。これらの検査は信頼性が高く、有効であり、適切な治療を決定するのに役立ちます。さらに、体内での性感染症（STI）の蔓延を防ぐ効果もあります。不妊検査は、子宮頸がんや子宮頸部周辺の異常細胞の発見にも役立ちます。そのため、病院、在宅医療、不妊治療クリニックなどで実施されています。

不妊検査市場の動向：

卵巣によるエストロゲンの過剰分泌に起因する多嚢胞性卵巣症候群（PCOS）のような疾患の有病率の増加は、市場を牽引する重要な要因の一つです。さらに、ライフスタイルの変化やストレスの増加、運動不足や食事パターンの変化による肥満が原因で、世界中で不妊率が上昇しています。これは、不妊検査の利点に関する大衆の意識の高まりとともに、市場の成長を後押ししています。さらに、大衆の間で不妊を治療するための技術的に高度な製品の発売は、市場にプラスの影響を与えています。これに加えて、主要市場参入企業は、すべての不妊関連データを一元化するための妊娠・排卵検査キットを導入するための研究開発活動に幅広く投資しています。これは、急成長する医療産業と相まって、業界の投資家に有利な成長機会を提供しています。これとは別に、精度の高い使いやすい不妊治療モニターに対する需要も増加しています。精子分析における人工知能（AI）の活用の高まりは、市場の成長を後押しすると予想されます。

本レポートで扱う主要質問

  • 2023年の世界の不妊検査市場規模は？
  • 2024～2032年にかけての世界の不妊検査市場の予想成長率は？
  • 不妊検査の世界市場を牽引する主要因は何か？
  • COVID-19が世界の不妊検査市場に与えた影響は？
  • 不妊検査の世界市場の製品別区分は？
  • 購入形態別の不妊検査の世界市場の内訳は？
  • 不妊検査の世界市場の用途別区分は？
  • エンドユーザー別の不妊検査の世界市場内訳は？
  • 不妊検査の世界市場における主要地域は？
  • 不妊検査の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の不妊検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 排卵日予測キット
  • 妊孕性モニター
  • 男性不妊検査製品

第7章 市場内訳：購入形態別

  • 市販薬
  • 処方薬

第8章 市場内訳：用途別

  • 女性不妊検査
  • 男性不妊検査

第9章 市場内訳：エンドユーザー別

  • 病院
  • 在宅ケア
  • 不妊治療クリニック
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AdvaCare Pharma
    • Ava AG
    • Babystart Ltd.（Snowden Healthcare）
    • Church & Dwight Co. Inc.
    • Fairhaven Health LLC
    • Geratherm Medical AG
    • Prestige Consumer Healthcare Inc.
    • Quidel Corporation
    • UEBE Medical GmbH
    • Valley Electronics AG
    • viO HealthTech Limited
図表

List of Figures

  • Figure 1: Global: Fertility Test Market: Major Drivers and Challenges
  • Figure 2: Global: Fertility Test Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Fertility Test Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Fertility Test Market: Breakup by Mode of Purchase (in %), 2023
  • Figure 6: Global: Fertility Test Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Fertility Test Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Fertility Test Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Fertility Test (Ovulation Prediction Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Fertility Test (Ovulation Prediction Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Fertility Test (Fertility Monitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Fertility Test (Fertility Monitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Fertility Test (Male Fertility Testing Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Fertility Test (Male Fertility Testing Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Fertility Test (OTC-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Fertility Test (OTC-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Fertility Test (Prescription-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Fertility Test (Prescription-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Fertility Test (Female Fertility Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Fertility Test (Female Fertility Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Fertility Test (Male Fertility Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Fertility Test (Male Fertility Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Fertility Test (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Fertility Test (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Fertility Test (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Fertility Test (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Fertility Test (Fertility Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Fertility Test (Fertility Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Fertility Test (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Fertility Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Fertility Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Fertility Test Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Fertility Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Fertility Test Industry: SWOT Analysis
  • Figure 81: Global: Fertility Test Industry: Value Chain Analysis
  • Figure 82: Global: Fertility Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fertility Test Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Fertility Test Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Fertility Test Market Forecast: Breakup by Mode of Purchase (in Million US$), 2024-2032
  • Table 4: Global: Fertility Test Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Fertility Test Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Fertility Test Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Fertility Test Market: Competitive Structure
  • Table 8: Global: Fertility Test Market: Key Players
目次
Product Code: SR112024A5810

The global fertility test market size reached US$ 552.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 927.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.

Fertility tests are performed to diagnose problems that prevent couples from conceiving. They comprise blood tests, pelvic examination, semen analysis, basal body temperature (BBT) charting, post coital test, transvaginal (pelvic) ultrasound exam, hysterosalpingogram or HSG, hysteroscopy, and laparoscopy. They are reliable, valid, and assist in determining a suitable treatment. In addition, they prevent the spread of sexually transmitted infections (STIs) in the body. Fertility tests also help detect cervical cancer and abnormal cells around the cervix. As a result, they are carried out in hospitals, home care, and fertility clinics.

Fertility Test Market Trends:

The growing prevalence of diseases, such as polycystic ovary syndrome (PCOS), due to the overproduction of estrogen by the ovaries represents one of the key factors driving the market. Moreover, there is a rise in infertility rates across the globe due to lifestyle changes and increasing stress and obesity, which is caused by a lack of physical exercise and alterations in dietary pattern. This, along with the increasing awareness among the masses about the benefits of fertility tests, is propelling the growth of the market. In addition, the launch of technologically advanced products to treat infertility among the masses is positively influencing the market. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce pregnancy and ovulation test kits for centralizing all fertility-related data. This, coupled with the burgeoning healthcare industry, is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for easy-to-use fertility monitors with high accuracy. The rising utilization of artificial intelligence (AI) in sperm analysis is expected to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global fertility test market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, mode of purchase, application and end user.

Breakup by Product:

Ovulation Prediction Kits

Fertility Monitors

Male Fertility Testing Products

Breakup by Mode of Purchase:

OTC-based

Prescription-based

Breakup by Application:

Female Fertility Testing

Male Fertility Testing

Breakup by End User:

Hospitals

Home Care Settings

Fertility Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AdvaCare Pharma, Ava AG, Babystart Ltd. (Snowden Healthcare), Church & Dwight Co. Inc., Fairhaven Health LLC, Geratherm Medical AG, Prestige Consumer Healthcare Inc., Quidel Corporation, UEBE Medical GmbH, Valley Electronics AG and viO HealthTech Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global fertility test market in 2023?
  • 2. What is the expected growth rate of the global fertility test market during 2024-2032?
  • 3. What are the key factors driving the global fertility test market?
  • 4. What has been the impact of COVID-19 on the global fertility test market?
  • 5. What is the breakup of the global fertility test market based on the product?
  • 6. What is the breakup of the global fertility test market based on the mode of purchase?
  • 7. What is the breakup of the global fertility test market based on the application?
  • 8. What is the breakup of the global fertility test market based on the end user?
  • 9. What are the key regions in the global fertility test market?
  • 10. Who are the key players/companies in the global fertility test market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fertility Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ovulation Prediction Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fertility Monitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Male Fertility Testing Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Mode of Purchase

  • 7.1 OTC-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prescription-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Female Fertility Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Male Fertility Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care Settings
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Fertility Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AdvaCare Pharma
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Ava AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Babystart Ltd. (Snowden Healthcare)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Church & Dwight Co. Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Fairhaven Health LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Geratherm Medical AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Prestige Consumer Healthcare Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Quidel Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 UEBE Medical GmbH
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Valley Electronics AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 viO HealthTech Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio